McGray, A. J. Robert
Huang, Ruea-Yea
Battaglia, Sebastiano
Eppolito, Cheryl
Miliotto, Anthony
Stephenson, Kyle B.
Lugade, Amit A.
Webster, Gill
Lichty, Brian D.
Seshadri, Mukund
Kozbor, Danuta
Odunsi, Kunle
Article History
Received: 19 February 2019
Accepted: 17 June 2019
First Online: 17 July 2019
Ethics approval
: All performed animal experiments and procedures were reviewed and approved by the Roswell Park Comprehensive Cancer Center (RPCCC) IACUC. No human subjects were enrolled in any aspect of this study.
: N/A.
: KB Stephenson is an employee of Turnstone Biologics, who holds IP for Maraba Virus. G Webster is the Chief Scientific Officer of Innate Immunotherapeutics, who holds IP for MIS416. BD Lichty is an inventor, shareholder, and Chief Technology Officer of Turnstone Biologics, who holds IP for Maraba Virus. All other authors have no financial competing interest to disclose.